Annual CFI
$3.25 M
+$16.65 M+124.27%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual cash flow from investing activities is $3.25 million, with the most recent change of +$16.65 million (+124.27%) on December 1, 2023.
- During the last 3 years, BRTX annual CFI has risen by +$3.25 million (+100.00%).
- BRTX annual CFI is now at all-time high.
Performance
BRTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$936.80 K
-$2.04 M-68.49%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly cash flow from investing activities is $936.80 thousand, with the most recent change of -$2.04 million (-68.49%) on September 1, 2024.
- Over the past year, BRTX quarterly CFI has increased by +$958.20 thousand (+4477.57%).
- BRTX quarterly CFI is now -68.49% below its all-time high of $2.97 million, reached on June 1, 2024.
Performance
BRTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$1.10 M
+$958.20 K+46.49%
September 1, 2024
Summary
- As of February 7, 2025, BRTX TTM cash flow from investing activities is -$1.10 million, with the most recent change of +$958.20 thousand (+46.49%) on September 1, 2024.
- Over the past year, BRTX TTM CFI has dropped by -$1.20 million (-1284.53%).
- BRTX TTM CFI is now -133.91% below its all-time high of $3.25 million, reached on December 1, 2023.
Performance
BRTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BRTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +124.3% | +4477.6% | -1284.5% |
| 3 y3 years | +100.0% | +3151.5% | -3492.2% |
| 5 y5 years | +10000.0% | +3151.5% | -3492.2% |
BRTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.3% | -68.5% | +109.5% | -133.9% | +91.8% |
| 5 y | 5-year | at high | +124.3% | -68.5% | +109.5% | -133.9% | +91.8% |
| alltime | all time | at high | +124.3% | -68.5% | +109.5% | -133.9% | +91.8% |
BioRestorative Therapies Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $936.80 K(-68.5%) | -$1.10 M(-46.5%) |
| Jun 2024 | - | $2.97 M(-160.3%) | -$2.06 M(-51.1%) |
| Mar 2024 | - | -$4.93 M(+5711.3%) | -$4.22 M(-229.6%) |
| Dec 2023 | $3.25 M(-124.3%) | -$84.80 K(+296.3%) | $3.25 M(+3393.0%) |
| Sep 2023 | - | -$21.40 K(-102.6%) | $93.10 K(-101.0%) |
| Jun 2023 | - | $819.00 K(-67.7%) | -$9.79 M(-8.9%) |
| Mar 2023 | - | $2.54 M(-178.3%) | -$10.75 M(-19.8%) |
| Dec 2022 | -$13.40 M(>+9900.0%) | -$3.24 M(-67.3%) | -$13.40 M(+31.5%) |
| Sep 2022 | - | -$9.91 M(+7096.1%) | -$10.19 M(+3564.4%) |
| Jun 2022 | - | -$137.70 K(+25.6%) | -$278.00 K(+98.1%) |
| Mar 2022 | - | -$109.60 K(+257.0%) | -$140.30 K(+357.0%) |
| Dec 2021 | -$30.70 K(<-9900.0%) | -$30.70 K(<-9900.0%) | -$30.70 K(<-9900.0%) |
| Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2020 | $0.00(-100.0%) | - | - |
| Dec 2019 | -$35.60 K(+176.0%) | $0.00(-100.0%) | -$35.70 K(0.0%) |
| Sep 2019 | - | -$6300.00(-78.6%) | -$35.70 K(+21.4%) |
| Jun 2019 | - | -$29.40 K(<-9900.0%) | -$29.40 K(+127.9%) |
| Dec 2018 | -$12.90 K(+258.3%) | $0.00(0.0%) | -$12.90 K(-21.8%) |
| Sep 2018 | - | $0.00(-100.0%) | -$16.50 K(0.0%) |
| Jun 2018 | - | -$12.90 K(+258.3%) | -$16.50 K(+358.3%) |
| Dec 2017 | -$3600.00(-98.1%) | -$3600.00(<-9900.0%) | -$3600.00(-47.1%) |
| Sep 2017 | - | $0.00(0.0%) | -$6800.00(-81.9%) |
| Jun 2017 | - | $0.00(-100.0%) | -$37.50 K(-80.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$188.80 K(-60.9%) | -$6800.00(-77.9%) | -$188.70 K(-17.8%) |
| Sep 2016 | - | -$30.70 K(-49.9%) | -$229.50 K(-43.7%) |
| Jun 2016 | - | -$61.30 K(-31.8%) | -$407.40 K(+0.4%) |
| Mar 2016 | - | -$89.90 K(+88.9%) | -$405.80 K(-16.0%) |
| Dec 2015 | -$483.10 K(+188.6%) | -$47.60 K(-77.2%) | -$483.10 K(-19.8%) |
| Sep 2015 | - | -$208.60 K(+249.4%) | -$602.30 K(+52.4%) |
| Jun 2015 | - | -$59.70 K(-64.3%) | -$395.20 K(+17.8%) |
| Mar 2015 | - | -$167.20 K(+0.2%) | -$335.50 K(+100.5%) |
| Dec 2014 | -$167.40 K(+1394.6%) | -$166.80 K(>+9900.0%) | -$167.30 K(+1329.9%) |
| Sep 2014 | - | -$1500.00(<-9900.0%) | -$11.70 K(+14.7%) |
| Jun 2014 | - | $0.00(-100.0%) | -$10.20 K(0.0%) |
| Mar 2014 | - | $1000.00(-108.9%) | -$10.20 K(-8.9%) |
| Dec 2013 | -$11.20 K(-98.9%) | -$11.20 K(<-9900.0%) | -$11.20 K(<-9900.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2013 | - | $0.00(0.0%) | -$1.00 M(0.0%) |
| Dec 2012 | -$1.00 M(-7159.9%) | $0.00(0.0%) | -$1.00 M(0.0%) |
| Sep 2012 | - | $0.00(-100.0%) | -$1.00 M(+3.3%) |
| Jun 2012 | - | -$1.00 M(<-9900.0%) | -$970.50 K(-4699.5%) |
| Mar 2012 | - | $0.00(0.0%) | $21.10 K(+48.6%) |
| Dec 2011 | $14.20 K(-129.1%) | $0.00(-100.0%) | $14.20 K(0.0%) |
| Sep 2011 | - | $32.00 K(-393.6%) | $14.20 K(-179.8%) |
| Jun 2011 | - | -$10.90 K(+58.0%) | -$17.80 K(+158.0%) |
| Mar 2011 | - | -$6900.00 | -$6900.00 |
| Dec 2010 | -$48.80 K | - | - |
FAQ
- What is BioRestorative Therapies annual cash flow from investing activities?
- What is the all time high annual CFI for BioRestorative Therapies?
- What is BioRestorative Therapies annual CFI year-on-year change?
- What is BioRestorative Therapies quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly CFI year-on-year change?
- What is BioRestorative Therapies TTM cash flow from investing activities?
- What is the all time high TTM CFI for BioRestorative Therapies?
- What is BioRestorative Therapies TTM CFI year-on-year change?
What is BioRestorative Therapies annual cash flow from investing activities?
The current annual CFI of BRTX is $3.25 M
What is the all time high annual CFI for BioRestorative Therapies?
BioRestorative Therapies all-time high annual cash flow from investing activities is $3.25 M
What is BioRestorative Therapies annual CFI year-on-year change?
Over the past year, BRTX annual cash flow from investing activities has changed by +$16.65 M (+124.27%)
What is BioRestorative Therapies quarterly cash flow from investing activities?
The current quarterly CFI of BRTX is $936.80 K
What is the all time high quarterly CFI for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly cash flow from investing activities is $2.97 M
What is BioRestorative Therapies quarterly CFI year-on-year change?
Over the past year, BRTX quarterly cash flow from investing activities has changed by +$958.20 K (+4477.57%)
What is BioRestorative Therapies TTM cash flow from investing activities?
The current TTM CFI of BRTX is -$1.10 M
What is the all time high TTM CFI for BioRestorative Therapies?
BioRestorative Therapies all-time high TTM cash flow from investing activities is $3.25 M
What is BioRestorative Therapies TTM CFI year-on-year change?
Over the past year, BRTX TTM cash flow from investing activities has changed by -$1.20 M (-1284.53%)